What’s Up with that Breast Implant Recall?
The FDA’s recall centers on a very specific type of implant: Allergan’s BIOCELL textured breast implants. According to an FDA press release, the reason for the recall is an alarming one:
“The FDA’s analysis was attributed to a new worldwide reported total of 573 unique BIA-ALCL cases including 33 patient deaths. Of the 573 cases of BIA-ALCL, 481 are reported to have Allergan breast implants at the time of diagnosis.”
So far, this specific implant product is the only one that demonstrates such an increased risk for BIA-ALCL.